Feedback / Questions
BIO-106 - BiOneCure
https://www.prnewswire.com/news-releases/bionecure-therapeutics-announces-fda-clearance-of-investigational-new-drug-ind-application-for-bio-106-a-novel-trop2-adc-for-the-treatment-of-advanced-solid-tumors-301518845.html
Apr 6, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev